
A Phase 3 Clinical Study Relatlimab™ + Nivolumab™ as investigational treatment for non-squamous (NSQ), Stage IV or recurrent NSCLC
The RELATIVITY-1093 clinical study is currently open for enrollment
Find Out More See how relatlimab works in NSCLC